We are currently researching novel therapeutic approaches to epilepsy, one of the most prevalent neurological disorders worldwide. Our goal is to develop new pharmacologic strategies that target the underlying mechanisms of seizure activity and neuroinflammation, improving patient outcomes and quality of life.